Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

ConditionParathyroid Adenomas

Trial statusAvailable

Trial phaseNot listed

Trial typeExpanded Access

Biological sexAll

Age13+

SponsorThomas Hope

About this trial

This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 13 years.

Evidence of primary hyperparathyroidism.

Ability to understand a written informed consent document, and the willingness to sign it.

Disqualifiers

None

Trial design

Treatments tested in this trial

18F-Fluorocholine (FCH)
Drug
A dose of 4-7 millicurie (mCi) +/- 10% of radiotracer 18F-Fluorocholine (FCH) manufactured at UCSF will be given intravenously.
Positron emission tomography (PET)
Procedure/Surgery
A scan is a procedure that produces images of organs and tissues used in conjunction with a radiotracer.

Treatment groups

No treatment groups listed

Trial outcomes

This trial has no outcomes listed.

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Thomas Hope

Lead sponsor

University of California, San Francisco

Sponsor institution

Source ClinicalTrials.gov

Apply now